Evidence map›Paper›PMID 24915262›Full record

ArticleJAMA2014

Association of a low-frequency variant in HNF1A with type 2 diabetes in a Latino population.

SIGMA Type 2 Diabetes Consortium, Karol Estrada, Ingvild Aukrust, Lise Bjørkhaug, Noël P Burtt, Josep M Mercader, Humberto García-Ortiz, Alicia Huerta-Chagoya, Hortensia Moreno-Macías, Geoffrey Walford and 42 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in JAMA, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 139 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
139citing papers in PubMed, 5 pooled it
24.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

139 citing papers in PubMed, 5 syntheses or guidelines pooled it, 269 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Article
  9. Type 2 diabetes genetics in 125,000 admixed adults from Mexico City.medRxiv : the preprint server for health sciences · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. bioRxiv : the preprint server for biology · 2025
    Article
  14. Review
  15. Article
  16. Review
  17. Phenotypic and Genetic Diversity in Diabetes Across Populations.The Journal of clinical endocrinology and metabolism · 2025
    Review
  18. Review
  19. Article
  20. Article

79 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
    Jiménez-Morales, Silvia[Added]
5 · Who and what money

Authors and funding

52 authors at 18 institutions in 4 countries.

SIGMA Type 2 Diabetes Consortium
Karol EstradaProgram in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, Massachusetts2Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston3Department of Medicine, Harvard Medical School, Boston, Massachusetts.
Ingvild AukrustKG Jebsen Center for Diabetes Research, Department of Clinical Science, University of Bergen, Bergen, Norway6Department of Biomedicine, University of Bergen, Bergen, Norway.
Lise BjørkhaugKG Jebsen Center for Diabetes Research, Department of Clinical Science, University of Bergen, Bergen, Norway5Department of Pediatrics, Haukeland University Hospital, Bergen, Norway.
Noël P BurttProgram in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
Josep M MercaderProgram in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, Massachusetts7Center for Human Genetic Research and Diabetes Research Center (Diabetes Unit), Massachusetts General Hospital, Boston8Joint BSC-CRG-IRB Research Prog.
Humberto García-OrtizInstituto Nacional de Medicina Genómica, Tlalpan, Mexico City, Mexico.
Alicia Huerta-ChagoyaInstituto de Investigaciones Biomédicas, UNAM Unidad de Biología Molecular y Medicina Genómica, UNAM/INCMNSZ, Coyoacán, Mexico City, Mexico.
Hortensia Moreno-MacíasUniversidad Autónoma Metropolitana, Tlalpan, Mexico City, Mexico.
Geoffrey WalfordDepartment of Medicine, Harvard Medical School, Boston, Massachusetts7Center for Human Genetic Research and Diabetes Research Center (Diabetes Unit), Massachusetts General Hospital, Boston.
Jason FlannickProgram in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, Massachusetts13Department of Molecular Biology, Harvard Medical School, Boston, Massachusetts.
Amy L WilliamsProgram in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, Massachusetts14Department of Biological Sciences, Columbia University, New York, New York.
María J Gómez-VázquezInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Sección XVI, Tlalpan, Mexico City, Mexico.
Juan C Fernandez-LopezInstituto Nacional de Medicina Genómica, Tlalpan, Mexico City, Mexico.
Angélica Martínez-HernándezInstituto Nacional de Medicina Genómica, Tlalpan, Mexico City, Mexico.
Silvia Jiménez-MoralesInstituto Nacional de Medicina Genómica, Tlalpan, Mexico City, Mexico.
Federico Centeno-CruzInstituto Nacional de Medicina Genómica, Tlalpan, Mexico City, Mexico.
Elvia Mendoza-CaamalInstituto Nacional de Medicina Genómica, Tlalpan, Mexico City, Mexico.
Cristina Revilla-MonsalveUnidad de Investigación Médica en Enfermedades Metabólicas, CMN SXXI, Instituto Mexicano del Seguro Social, Mexico City.
Sergio Islas-AndradeUnidad de Investigación Médica en Enfermedades Metabólicas, CMN SXXI, Instituto Mexicano del Seguro Social, Mexico City.
Emilio J CórdovaInstituto Nacional de Medicina Genómica, Tlalpan, Mexico City, Mexico.
Xavier SoberónInstituto Nacional de Medicina Genómica, Tlalpan, Mexico City, Mexico.
María E González-VillalpandoCentro de Estudios en Diabetes, Unidad de Investigacion en Diabetes y Riesgo Cardiovascular, Centro de Investigacion en Salud Poblacional, Instituto Nacional de Salud Publica, Mexico City, Mexico.
E HendersonDepartment of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles.
Lynne R WilkensEpidemiology Program, University of Hawaii Cancer Center, Honolulu.
Loic Le MarchandEpidemiology Program, University of Hawaii Cancer Center, Honolulu.
Olimpia Arellano-CamposInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Sección XVI, Tlalpan, Mexico City, Mexico.
Maria L Ordóñez-SánchezInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Sección XVI, Tlalpan, Mexico City, Mexico.
Maribel Rodríguez-TorresInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Sección XVI, Tlalpan, Mexico City, Mexico.
Rosario Rodríguez-GuillénInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Sección XVI, Tlalpan, Mexico City, Mexico.
Laura RibaInstituto de Investigaciones Biomédicas, UNAM Unidad de Biología Molecular y Medicina Genómica, UNAM/INCMNSZ, Coyoacán, Mexico City, Mexico.
Laeya A NajmiKG Jebsen Center for Diabetes Research, Department of Clinical Science, University of Bergen, Bergen, Norway23Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway.
Suzanne B R JacobsProgram in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
Timothy FennellThe Genomics Platform, The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
Stacey GabrielThe Genomics Platform, The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
Pierre FontanillasProgram in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
Craig L HanisHuman Genetics Center, University of Texas Health Science Center at Houston.
Donna M LehmanDepartment of Medicine, University of Texas Health Science Center at San Antonio.
Christopher P JenkinsonDepartment of Medicine, University of Texas Health Science Center at San Antonio.
Hanna E AbboudDepartment of Medicine, University of Texas Health Science Center at San Antonio.
Graeme I BellDepartment of Human Genetics, University of Chicago, Chicago, Illinois28Department of Medicine, University of Chicago, Chicago, Illinois.
Maria L CortesBroad Institute of Harvard and MIT, Cambridge, Massachusetts.
Michael BoehnkeDepartment of Biostatistics, Center for Statistical Genetics, University of Michigan, Ann Arbor.
Clicerio González-VillalpandoCentro de Estudios en Diabetes, Unidad de Investigacion en Diabetes y Riesgo Cardiovascular, Centro de Investigacion en Salud Poblacional, Instituto Nacional de Salud Publica, Mexico City, Mexico.
Lorena OrozcoInstituto Nacional de Medicina Genómica, Tlalpan, Mexico City, Mexico.
Christopher A HaimanDepartment of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles.
Teresa Tusié-LunaInstituto de Investigaciones Biomédicas, UNAM Unidad de Biología Molecular y Medicina Genómica, UNAM/INCMNSZ, Coyoacán, Mexico City, Mexico17Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Sección XVI, Tlalpan, Mexico City, Mexico.
Carlos A Aguilar-SalinasInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Sección XVI, Tlalpan, Mexico City, Mexico.
David AltshulerProgram in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, Massachusetts3Department of Medicine, Harvard Medical School, Boston, Massachusetts7Center for Human Genetic Research and Diabetes Research Center (Diabetes Unit).
Pål R NjølstadKG Jebsen Center for Diabetes Research, Department of Clinical Science, University of Bergen, Bergen, Norway5Department of Pediatrics, Haukeland University Hospital, Bergen, Norway.
Jose C FlorezProgram in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, Massachusetts3Department of Medicine, Harvard Medical School, Boston, Massachusetts7Center for Human Genetic Research and Diabetes Research Center (Diabetes Unit).
Daniel G MacArthurProgram in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, Massachusetts3Department of Medicine, Harvard Medical School, Boston, Massachusetts.
National Institute of Genomic Medicine · MXBroad Institute · USInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXMassachusetts General Hospital · USThe University of Texas Health Science Center at San Antonio · USUniversity of Bergen · NOInstituto Nacional de Salud Pública · MXMexican Social Security Institute · MXUniversidad Nacional Autónoma de México · MXUniversity of Hawaii Cancer CenterUniversity of Southern California · USColumbia University · USHarvard University · USHaukeland University Hospital · NOStatistical Research (United States) · USThe University of Texas Health Science Center at Houston · USUniversidad Autónoma Metropolitana · MXUniversity of Chicago · US

Funding

Understanding Population Differences in Cancer: The MEC StudyU01CA164973 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI HAIMAN, CHRISTOPHER ALAN, LE MARCHAND, LOIC · 2015 to 2025
$37.4M
PEDIGREE ANALYSIS OF LIPOPROTEIN PHENOTYPESP01HL045522 · NHLBI · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI BLANGERO, JOHN · 1991 to 2012
$27.6M
Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
GENETIC SUSCEPTIBILITY TO CANCER IN MULTIETHNIC COHORTSR01CA063464 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HENDERSON, BRIAN E · 2001 to 2005
$23.2M
Multiethnic Cohort Study of Diet and CancerR37CA054281 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI KOLONEL, LAURENCE N. · 2003 to 2012
$23.2M
Multiethnic Study of Type 2 Diabetes GenesU01DK085526 · NIDDK · BROAD INSTITUTE, INC. · PI ALTSHULER, DAVID, JABLONSKI, KATHLEEN ANN · 2009 to 2014
$15.7M
Identifying Genes for Type 2 Diabetes: FUSIONU01DK062370 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BOEHNKE, MICHAEL L, SCOTT, LAURA J. · 2009 to 2021
$11.6M
Understanding Ethnic Differences in Cancer: The Multiethnic Cohort StudyUM1CA164973 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI HENDERSON, BRIAN E, LE MARCHAND, LOIC · 2012 to 2014
$11.3M
Prospective studies of cancer etiology and prevention in Shanghai and SingaporeR01CA144034 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI YUAN, JIAN-MIN · 2010 to 2014
$7.0M
NIDDM SUSCEPTIBILITY GENES IN MEXICAN-AMERICANSR01DK047482 · NIDDK · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI LEHMAN, DONNA M · 1993 to 2010
$5.4M
THE SINGAPORE COHORT STUDY OF DIET AND CANCERR01CA080205 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI YUAN, JIAN-MIN · 1999 to 2009
$5.3M
MULTIETHNIC/MINORITY COHORT STUDY OF DIET AND CANCERR01CA054281 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI KOLONEL, LAURENCE N. · 1993 to 2002
$4.5M
NCI NIH HHS CA054281NCI NIH HHS CA063464NCI NIH HHS CA164973NCI NIH HHS R01 CA054281NCI NIH HHS R01 CA055069NCI NIH HHS R01 CA063464NCI NIH HHS R01 CA080205NCI NIH HHS R01 CA144034NCI NIH HHS R01 CA80205NCI NIH HHS R35 CA053890NCI NIH HHS R35CA53890NCI NIH HHS R37 CA054281NCI NIH HHS U01 CA063464NCI NIH HHS U01 CA164973NCI NIH HHS UM1 CA164973NHLBI NIH HHS P01 HL045522NHLBI NIH HHS P01HL045522NHLBI NIH HHS R01HL24799NIDDK NIH HHS P30 DK020572NIDDK NIH HHS R01 DK033665NIDDK NIH HHS R01 DK042273NIDDK NIH HHS R01 DK047482NIDDK NIH HHS R01DK047482NIDDK NIH HHS R01 DK053889NIDDK NIH HHS R01DK053889NIDDK NIH HHS R01 DK057295NIDDK NIH HHS R01 DK098032NIDDK NIH HHS U01 DK057295NIDDK NIH HHS U01 DK062370NIDDK NIH HHS U01 DK085501NIDDK NIH HHS U01DK085501NIDDK NIH HHS U01 DK085526NIDDK NIH HHS U01DK085526
6 · The paper itself

Abstract

importanceLatino populations have one of the highest prevalences of type 2 diabetes worldwide.

objectivesTo investigate the association between rare protein-coding genetic variants and prevalence of type 2 diabetes in a large Latino population and to explore potential molecular and physiological mechanisms for the observed relationships. DESIGN, SETTING, AND

participantsWhole-exome sequencing was performed on DNA samples from 3756 Mexican and US Latino individuals (1794 with type 2 diabetes and 1962 without diabetes) recruited from 1993 to 2013. One variant was further tested for allele frequency and association with type 2 diabetes in large multiethnic data sets of 14,276 participants and characterized in experimental assays. MAIN OUTCOME AND MEASURES: Prevalence of type 2 diabetes. Secondary outcomes included age of onset, body mass index, and effect on protein function.

resultsA single rare missense variant (c.1522G>A [p.E508K]) was associated with type 2 diabetes prevalence (odds ratio [OR], 5.48; 95% CI, 2.83-10.61; P = 4.4 × 10(-7)) in hepatocyte nuclear factor 1-α (HNF1A), the gene responsible for maturity onset diabetes of the young type 3 (MODY3). This variant was observed in 0.36% of participants without type 2 diabetes and 2.1% of participants with it. In multiethnic replication data sets, the p.E508K variant was seen only in Latino patients (n = 1443 with type 2 diabetes and 1673 without it) and was associated with type 2 diabetes (OR, 4.16; 95% CI, 1.75-9.92; P = .0013). In experimental assays, HNF-1A protein encoding the p.E508K mutant demonstrated reduced transactivation activity of its target promoter compared with a wild-type protein. In our data, carriers and noncarriers of the p.E508K mutation with type 2 diabetes had no significant differences in compared clinical characteristics, including age at onset. The mean (SD) age for carriers was 45.3 years (11.2) vs 47.5 years (11.5) for noncarriers (P = .49) and the mean (SD) BMI for carriers was 28.2 (5.5) vs 29.3 (5.3) for noncarriers (P = .19). CONCLUSIONS AND RELEVANCE: Using whole-exome sequencing, we identified a single low-frequency variant in the MODY3-causing gene HNF1A that is associated with type 2 diabetes in Latino populations and may affect protein function. This finding may have implications for screening and therapeutic modification in this population, but additional studies are required.

Indexed as

AdultAgedAge of OnsetDiabetes Mellitus, Type 2FemaleGenotypeHepatocyte Nuclear Factor 1-alphaHispanic or LatinoHumansMaleMexicoMiddle AgedMutation, MissenseSequence Analysis, DNAUnited StatesHepatocyte Nuclear Factor 1-alphaHNF1A protein, human

Identifiers

PMID24915262
PMCPMC4425850
OpenAlexW2055830789

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.